UC Skin Cancer Experts in Cuba
UC Health dermatologists Hugh Gloster, MD, and Adam Ingraffea, MD, were among nearly 80 dermatologists to visit Cuba at a dermatologist information exchange organized by the Skin Cancer Foundation.
Both Gloster and Ingraffea are skin cancer experts on faculty in the University of Cincinnati (UC) College of Medicine Department of Dermatology and are members of the UC Cancer Institute.
While their visas did not permit the group of visiting dermatologists to go inside clinics or hospitals, doctors from both countries were able to present on their standards of dermatological care and current practices at an informal gathering during the seven day stay.
Ingraffea, an assistant professor in the department of dermatology, summarized the health care system in Cuba as "having a ton of well-trained doctors and they do a lot of primary care there, but it is basically a Third World country with universal health care. They have more dermatologists per capita
skin cancer is on the rise there with 8,000 to 10,000 cases a year
but they dont have many treatments for skin cancer or a lot of modern technology.
"It was really neat to see the different way of doings things
and how the same profession operates in a completely different system.
Ingraffea says there are talks underway to bring a Cuban dermatologist to Cincinnati to train with him and Gloster on Mohs surgery, a microscopically controlled surgery used to treat common types of skin cancer. During the surgery, after each removal of tissue, the pathologist examines the tissue specimen for cancer cells, and that examination informs the surgeon where to remove tissue next.
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.